Biotechnology commercialization in Europe

Authors

  • Dana Ukropcová BioScience Slovakia Limited, Kostliveho 10, Bratislava, SK-821 03, Slovak Republic
  • Ernest Šturdík Institute of Biochemistry, Nutrition and Health Protection, Faculty of Chemical and Food Technology, Slovak University of Technology, Radlinskeho 9, Bratislava, SK-812 37, Slovak Republic

DOI:

https://doi.org/10.36547/nbc.1134

Keywords:

commercialisation, biotechnology, technology transfer, spin-off

Abstract

European biotechnology was mapped for research and commercialisation from various information sources. Social and economical benefits from technology transfer in biotechnology are clearly visible in those European countries where proper attention is given to bioscience entrepreneurship education alongside with scientific base creation and spin-off development. Successful bioscience commercialisation is a result of a coordinated support of research and specific commercialisation programmes leading to spinoff establishment and industry partnership.

Downloads

Published

2021-09-02

How to Cite

Ukropcová, D., & Šturdík, E. (2021). Biotechnology commercialization in Europe. Nova Biotechnologica Et Chimica, 9(3), 255–264. https://doi.org/10.36547/nbc.1134

Issue

Vol. 9 No. 3 (2009)

Section

Reviews

License

Copyright (c) 2021 Dana Ukropcová, Ernest Šturdík

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers published in the Nova Biotechnologica et Chimica (NBC)  are published under a CC-BY licence (CC-BY 4.0). Published materials can be shared (copy and redistribute the material in any medium or format) and adapted (remix, transform, and build upon the material for any purpose, even commercially) with specifying the author(s).